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Despite intensive research and medical advances met, metastatic disease remains the most common
cause of death in cancer patients. This results from late diagnosis, poor therapeutic response and un-
detected micrometastases and tumor margins during surgery. One approach to overcome these chal-
lenges involves ﬂuorescence imaging, which exploits the properties of ﬂuorescent probes for diagnostic
detection of molecular structures at the onset of transformation and for intraoperative detection of
metastases and tumor margins in real time. Considering these beneﬁts, many contrast agents suitable for
ﬂuorescence imaging have been reported. However, most reports only demonstrate the detection of
primary tumors and not the detection of metastases or their application in models of image-guided
surgery.
In this work, we demonstrate the inﬂuence of ﬁbroblast activation protein (FAP) on the metastatic
potential of ﬁbrosarcoma cells and elucidate the efﬁcacy of activatable FAP-targeting immunoliposomes
(FAP-IL) for image-guided detection of the spontaneous metastases in mice models. Furthermore, we
characterized the biodistribution and cellular localization of the liposomal ﬂuorescent components in
mice organs and traced their excretion over time in urine and feces. Taken together, activatable FAP-IL
enhances intraoperative imaging of metastases. Their high accumulation in metastases, subsequent
localization in the bile canaliculi and liver kupffer cells and suitable excretion in feces substantiates their
potency as contrast agents for intraoperative imaging.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Two key factors that control the progression of cancer are the
growth and survival of the tumor cells and their dissemination to
distant host tissues, leading to metastasis. Although accumulating
evidence reveal that the emergence of metastasis is preceded by
circulating malignant cells which also exist in the absence of
pathologically detectable primary tumors [1,2], metastatic disease
remains the most common cause of death in cancer patients. A bulk
of reports reveals a major role of the tumor microenvironment in.L. Tansi), ronny.rueger@web.
r).
Ltd. This is an open access article umetastasis formation [3,4]. Thus, formation of metastasis requires
the proteolysis of the extracellular matrix (ECM) and basement
membranes for intravasation and extravasation of tumor cells and
also their reattachment and proliferation at distant organs. Pro-
teases such as matrix metalloproteinases (MMP), plasminogen ac-
tivators and serine proteases secreted from invading tumor and
tumor stroma cells, for example ﬁbroblast activation protein (FAP)
are responsible for the degradation of ECM components. Accumu-
lating evidence reveals a strong correlation between elevated levels
of metalloproteinases in cancer cells and an invasive phenotype
[5,6]. Elevated levels of ﬁbroblast activation protein, (FAP) on
stromal ﬁbroblasts also correlate with the invasiveness of many
cancer types [7e11]. Imaging the molecular and cellular changes
that control the invasive behavior of single cells, and their transi-
tion to aggressive metastasizing cells is vital for early diagnosis and
patient staging for therapy. In present day clinical setups,nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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markers for example carcinoembryonal antigen (CEA) levels in
breast cancers, in combination with whole body ﬂuorodeox-
yglucose positron emission tomography (FDG-PET)-computed to-
mography (CT) or whole body magnetic resonance imaging (MRI)
[12]. Despite the accuracy of these systems for cancer and metas-
tases detection, with a 10 mm or 12 mm axial size for MRI and CT
respectively [13], a high level of metastases emergence and cancer
recurrence is noted in patients after primary therapy. This can
partly be ascribed to incomplete resection of primary tumor mar-
gins, since the surgeon cannot monitor the tumorous margins in
real time during surgery. Therefore, modalities that permit image-
guided surgery of tumorous tissue andmetastatic tumormargins in
real time are needed.
Near infrared ﬂuorescence (NIRF) imaging permits early diag-
nosis and intraoperative imaging of diseased tissues in real time,
and has revealed promising results in preclinical studies and early
advances in humans [14e16]. It represents the non-invasive utili-
zation of light to detect ﬂuorescent contrast agents directed to
transformed molecular structures or tissues in diverse diseases. For
in vivo purposes, suitable ﬂuorescent probes have their absorption
and emission properties within the near-infrared (NIR) window
[17], where tissue auto-ﬂuorescence based on water and hemo-
globin are minimal. With respect to this observation, several near-
infrared ﬂuorescent dyes have been developed and conjugated for
example to antibodies [18,19] and nanoparticles [20] or encapsu-
lated within lipidic nanomaterials [21,22] to serve as contrast
agents for molecular imaging of different neoplasms. Molecular
targets such as the ﬁbroblast activation protein (FAP) are inter-
esting targets for molecular imaging. FAP, a type II sialoglycoprotein
and proteolytic enzyme which cleaves several biological peptides
including collagen, plays a central role in the invasiveness of solid
tumors and has gained increasing interest as a tumormarker owing
to its expression on 90% of the stromal ﬁbroblasts of many cancer
types and healing wounds, but not on healthy tissues [7,23]. The
development of diagnostic approaches targeting FAP is therefore
vital for a broad spectrum of cancer types. Thus, FAP-targeting
probes that serve as non-invasive imaging tools for early detec-
tion of cancers have been reported in in vitro [24e26] and also in
in vivo studies, but show no data on the detection of metastasis or
in intraoperative applications [22,27]. Considering the role of
metastasis in cancer recurrence and mortality, it is crucial to
include the detection of metastases as a criterion when character-
izing imaging probes. Additionally, it is important to ensure a
suitable elimination of the probes from the system after the
required application is complete [14,28,29]. This eliminates
possible adverse side effects that may be caused by probes that stay
in the system for very long durations.
In recent ﬁndings, we demonstrated that activatable, non-
targeted, PEGylated liposomes (Lip-Q) ﬂuoresce exclusively after
their cellular uptake and activation by phagocytic cells, due to
encapsulation of quenched concentrations of a near-infrared ﬂuo-
rescent (NIRF) dye in the aqueous interior [21,30]. Moreover,
conjugation of an anti-FAP'scFv antibody fragment to the quenched
liposomes (FAP-IL) guaranteed speciﬁcity and ﬂuorescence imaging
of FAP expressing cells and tumor myoﬁbroblasts in xenografted
primary tumors in mice [22]. Considering the importance of
detecting invisible metastases, suspicious lymph nodes and
tumorous margins during image-guided surgery in real time, the
objective of the underlying study was therefore to evaluate if FAP-IL
is a potent contrast agent that drives intraoperative imaging of
ﬁbrosarcoma-derived spontaneous metastases and suspicious
lymph nodes. Also, we aimed to pinpoint the organs and routes
involved in the elimination of the liposomal components. We show
that high expression of FAP in stably transfected ﬁbrosarcoma cellsinﬂuence their motility and metastatic potential, leading to spon-
taneous metastases which could be detected by FAP-IL. Besides the
imaging of micro and macrometastases of lungs and colon, FAP-IL-
based ﬂuorescence detection of metastatic lymph nodes was
possible, as demonstrated by intraoperative imaging. Furthermore,
liposomal ﬂuorescence could be determined macroscopically in
liver, bile and kidneys and localized microscopically to kupffer cells
and bile canaliculi of the liver and to the renal pyramids of the
kidneys. Consistent with the elimination of the liposomal compo-
nents via the liver and kidney, urine and feces collected from 0 to
24 h post probe injection revealed ﬂuorescence of the liposomal
near-infrared dye. Our ﬁndings indicate that activatable FAP-IL is a
potent contrast agent for intraoperative detection of invasive tumor
margins and metastases in real time.
2. Materials and methods
2.1. Preparation and characterization of activatable liposomes and
FAP-targeting immunoliposomes
The liposomes were prepared as reported earlier [21,22] and
summarized in Ref. [31].
2.2. Veriﬁcation of the liposomal stability, quenching and activation
potential in vitro
Immediately after each preparation, the sizes of liposomes were
measured via dynamic light scattering and the zeta potentials
determined by using a Zetasizer Nano ZS (Malvern, Herrenberg,
Germany). Furthermore, the ﬂuorescence-quenching and activa-
tion effects were analyzed in vitro, by measuring the absorption
(Ultrospec 4000) and ﬂuorescence emission (Jasco FP6200) before
and after liposomal freeze-damaging of 200 nmol (ﬁnal lipid) in
100 ml of a 10 mM Tris pH 7.4 as described earlier [21]. To monitor
the effect of serum on free DY-676-COOH and dye release from FAP-
IL, the samples were incubated for 4 h at 37 C in equal volumes of
fetal calf serum (making 50% FCS). The samples were then diluted
with Tris buffer to get a ﬁnal 10% FCS before measurements. To
verify if liposomes stored for 1 year at 4 C were stable and retained
their size, homogeneity and activatability, the measurements were
repeated 12 months after preparation.
2.3. Cell lines
MDA-MB435S, a human Melanoma cell line, and the mouse
macrophage cell line J774A.1 were from the Cell Lines Service, (CLS,
Heidelberg, Germany) whereas the Fibrosarcoma cell line, HT1080
and its FAP-transfected counterparts HT1080-hFAP (human FAP)
and HT1080-mFAP (murine FAP) were got from Prof. Roland Kon-
termann's Lab at the IZI University Stuttgart. TheMDA-MB435S and
J774A.1 cells were cultured in Dulbecco's modiﬁed Eagle's medium
supplemented with 10% (v/v) fetal calf serum (FCS) and 1% Hepes
(GIBCO BRL, Scotland) and the HT1080 cells cultured in RPMI me-
dium supplemented with 5% (v/v) fetal calf serum (both GIBCO BRL,
Scotland) and grown at 37 C in a 5% CO2 and 95% humidiﬁed
atmosphere.
2.4. Cell motility and invasion assays
Cell motility assays were performed with the CytoSelect™ 24-
well wound healing assay kit (Cell Biolabs Inc., Germany) accord-
ing to the manufacturer's instructions. Brieﬂy, the investigated cells
(HT1080-wt, HT1080-hFAP and MDA-MB435S) were plated in 24-
well plates with the “wound ﬁeld” inserts in place and grown to
80% conﬂuence. The inserts were removed and unattached cells
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cells further cultured overnight for 24 h. Cell growth and migration
into the “wound ﬁelds” were evaluated microscopically following
staining with the crystal violet cell staining solution included in the
kit. For cell motility assay with subsequent liposomal uptake and
confocal microscopy, 30,000 cells were grown to 80% conﬂuency in
8-well chamber slides and “wound ﬁelds” scratched with a 1000 ml
pipette tip according to [32]. The cells were then washed carefully.
Thereafter, 200 nmol (ﬁnal lipids) were added and the cells
cultured for further 24 h. Nuclei stain and mounting with Hoechst-
33258 in Permaﬂuor and confocal microscopy of ﬂuorescing cells in
the wound areas was performed as described for the other cellular
uptake experiments.
The ability of the cells to invade a matrix basement membrane
was veriﬁed with the CytoSelect™ 24-well cell invasion assay
(basement membrane) kit (Cell Biolabs Inc., Germany) according to
the user manual. 100,000 cells of the investigated cell suspensions
(HT1080-wt, HT1080-hFAP and MDA-MB435S) were seeded in the
upper chamber then the chambers placed in the lower reservoir
containing fresh culture medium supplemented with 5% FCS or
lacking serum. The cells were cultured at standard growth condi-
tions and the different levels of invasion quantiﬁed as stated in the
instruction manual. Optical densities resulting from the stained
invasive cells were determined at l560 nm on a Tecan Inﬁnite
M1000 plate reader (TECAN, Crailsheim, Germany).
2.5. Uptake of liposomal probes and imaging
For confocal microscopy evaluation of the selective uptake of
FAP-IL, 30,000 cells (HT1080, HT1080-hFAP, HT1080-mFAP) and
50,000 cells (J774A.1) were seeded on poly-L-lysine-coated 8-well
culture slides (BD Biosciences) and grown for 16 h. Thereafter,
200 nmol (ﬁnal lipid) of the liposomes or free DY-676-COOH (at a
concentration equivalent to the dye content in the FAP-IL used)
were added and the cells further cultured for the indicated dura-
tions at 37 C or 4 C. To harvest, the cells werewashed 3 times with
HBSS and ﬁxed with 3.7% (v/v) formaldehyde (Roth, Karlsruhe,
Germany) in PBS for 30 min at RT. After 2 further wash steps with
PBS, the chambers were separated and mounting solution (Per-
maFluor, ThermoFischer) containing the DNA stain Hoechst-33258
(Applichem) was dropped on the cells then covered with glass
cover-slips and subsequently imaged on the LSM510-META
confocal microscope (Zeiss, Jena, Germany). Cell nuclei were visu-
alizedwith a 405 nm laser diode and a 420e480 nm bandpass ﬁlter.
The ﬂuorescence of NBD-DOPE was detected with the GFP ﬁlter at
530 nm after excitation at 488 nm. DY-676-COOH was excited with
a 633 nm Argon Laser and emission captured with a 650 nm
longpass ﬁlter. All images were acquired at a 63x magniﬁcation.
2.6. Animals and implantation
All procedures were approved by the regional animal committee
and were in accordancewith international guidelines on the ethical
use of animals. 10e18 weeks old female athymic nude mice
(Hsd:Athymic Nude-Foxn1nu nu/nu; Harlan Laboratories) weighing
approximately 24 g were housed under standard conditions with
food and water ad libitum. 28e42 days prior to in vivo imaging,
xenografts were induced by implanting 1.0 106 cells (HT1080-wt)
and 1.5  106 cells (HT1080-hFAP). Brieﬂy, the cells were pelleted
and dispensed in 120 ml cold Matrigel™ (BD Biosciences) then
injected subcutaneously into the lower back of the mice either
adjacent to each other on the same mouse or separately on indi-
vidual mice. Seven days prior to probe injection and imaging, all
mice received a low pheophorbide diet (C1039, Altromin) in order
to reduce tissue auto-ﬂuorescence. Throughout all procedures,animals were anesthetized with 2% isoﬂurane.
2.7. Determination of tumor volumes
The length, width and heights of tumors were measured with a
digital caliper and the corresponding volumes calculated in two
dimensions according to Feldmann [33] using the formula: V ¼ p/6
x (length x width x height).
2.8. NIRF imaging of whole animals and excised organs and semi-
quantitative analyses of the ﬂuorescence intensities
Mice implanted 4e6 weeks earlier and bearing subcutaneous
xenografts with approximate diameters of 5e10 mm were anes-
thetized with 2% isoﬂurane and the respective probes injected
intravenously through the tail vein. To control for signal speciﬁcity,
the non-targeted control LipQ was used. The animals were imme-
diately imaged and recordings made as time point, t ¼ 0 h post
injection (p.i.) and further imaged every 2 h for 10 h and again at
t ¼ 24 h p.i. Images were acquired with the Maestro™ in vivo
ﬂuorescence imaging system (Cri-InTAS, Woburn USA) by exciting
with ﬁlters for the excitation range 615e665 nm and acquiring
emission with a cut-in ﬁlter (>700 nm). The evaluation and sub-
traction of background auto-ﬂuorescence of native animals were
performed with the Maestro software. Excised organs were imaged
similar to the whole animals. Semi-quantitative determination of
the ﬂuorescence intensities of tumors or organswere donewith the
Maestro software, by assigning a region of interest (ROI) to the
desired specimen. Fluorescence intensities were given as average
signal (scaled counts/s). This represents ﬂuorescence levels after
scaling for exposure time, camera gain, binning and bit depth,
making the measurements comparable among each other.
2.9. Ex vivo determination of the biodistribution of FAP-IL
24 h post injection of FAP-IL, control LipQ or the free DY-676-
COOH at a concentration equivalent to the dye content of LipQ
used, the animals were sacriﬁced and the organs and tumors were
imaged. Semi-quantitative levels of the respective ﬂuorescence
intensities were determined with the Maestro software as
described above.
2.10. NIRF life imaging of mice and intraoperative detection of
metastases
Life imaging was performed with the Fluobeam™ 700 (Fluop-
tics, Grenoble France; Excitation 680 nm/Emission >700 nm).
Owing to interference by environmental light, all the imaging
procedures were performed in the dark by covering the system
with a cardboard box cut open on one side and covered with a
green surgical cloth. The exposure timewasmaintained at 200milli
seconds (ms) during injection and from 10 h post injection. Be-
tween 2 h and 8 h post injection the ﬂuorescence of certain organs
were so high that the exposure time had to be reduced to
50e100 ms. The intraoperative simulation was performed on
euthanized mice 16e22 h post probe injection.
2.11. Collection and analysis of urine and feces
At designated time points post probe injection, directly after
imaging, mice were placed on a plastic foil in a separate cage and
observed for 5e10 min. In most cases the mice urinated and
excreted after recovering from the effect of anesthesia. The urine
was pipetted into a sterile tube, whereas the fecal particles were
collected and placed on an imaging platform. Specimens collected
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in vivo ﬂuorescence imaging system as stated above.
2.12. Euthanasia
Animals were ﬁrst anesthetized with 2% isoﬂurane till they no
longer reacted to touch, then euthanized with carbon dioxide for
5e10 min and controlled till they completely stopped breathing.
2.13. Confocal microscopy of freshly isolated organs
Immediately after excision, livers and kidneys were quickly
rinsed in sterile PBS. A small piece of the freshly excised liver or
kidney was smoothly cut with a sharp scalpel and placed with the
smooth surface lying on a glass coverslip of a 4-well cell culture
coverslip chamber slide. To avoid dehydration during microscopy, a
drop of PBS was placed in one empty well and the chamber slides
covered and subjected to microscopy. The strong tissue auto-
ﬂuorescence (blue to green ﬂuorescence) of the fresh organs per-
mits visualization of the organ structures, whereby probes with
ﬂuorescence absorption and emission maxima beyond the auto-
ﬂuorescence range (e.g. DY-676-COOH: abs/em. 674/699 nm) can
be clearly distinguished. Images were acquired at similar excitation
and emission settings like in cellular uptake experiments, with the
exception that the organ images were acquired at a 40x
magniﬁcation.
2.14. Histology and immunohistochemistry
After imaging and euthanasia, the tumors and desired organs
were ﬁxed in methanol-stabilized 5% formaldehyde solution (Otto-
Fischer GmbH, Germany) for 24 h at 4 C, then embedded in
parafﬁn. Using a microtome system (Microm HM 340E, Thermo-
Fischer), three-micron thick serial sections of the samples were
sliced, mounted on (poly-L-lysin)-coated glass slides and air-dried.
The slices were dewaxed, by 2  5 min incubation in xylol, 5 min in
96% ethanol, 5 min in 70% ethanol, 5 min in 50% ethanol and ﬁnally
5 min in double distilled water. The nuclei were stained by 5 min
incubation in hematoxylin followed by a 2x wash step in double
distilled water and a ﬁnal wash step in lukewarm tap water till the
nuclei became dark blue. Counterstain of the cytoplasm was per-
formed with 0.1% eosin B solution. Hereby, the slides were incu-
bated for 3 min in the solution then washed twice for 5 min with
distilled water. Dehydration of the slices was performed by 1 min
incubations in 50%, 70% and 96% ethanol, followed by a short in-
cubation in xylol. The slides were placed on a ﬂat slide holder,
quickly mounted with Pertex synthetic mounting solution (PER
20000, medite GmbH, Burgdorf Germany) and covered with glass
coverslips. The slides were air dried for 16e24 h and whole mount
(tile scan) 4x images of the specimens acquired with a Keyence-
BZ9000 microscope (Keyence Deutschland GmbH) or 60x magni-
ﬁcations performed with the Olympus BX50 Microscope (Olympus
GmbH, Germany). To detect ﬂuorescence in tumors from mice
injected with FAP-IL, slices were dewaxed, washed and the speci-
mens directly mounted with PermaFluor containing the nuclei
stain Hoechst-33258 and subjected to confocal microscopy as
stated above.
2.15. Statistical data
Except indicated otherwise, student's t-test was used to deduce
the level of signiﬁcance, if normality and equal variance tests were
passed. If not, Mann-Whitney-Rank sum test was applied. All ex-
periments were done at least twice. In in vivo animal trials 4 or
more animals/group were used. Differences resulting in P < 0.05were considered signiﬁcant.
3. Results
3.1. Activatable FAP-IL liposomes retain quenched property and
speciﬁcity to FAP-expressing cells
Liposomes prepared by the standard ﬁlm-hydrationmethod and
encapsulated with high concentrations of the NIRF dye, DY-676-
COOH were stable for over 1 year at 4 C when stored in 10 mM
Tris, pH 7.4. This stability was evident in the minimal alteration in
size, polydispersity indices, zetapotential and concentration of the
encapsulated DY-676-COOH determined 12 months after prepara-
tion (Table 1). Also, the ﬂuorescence quenching and activation
potential of FAP-IL, as well as its ability to bind and be taken up by
FAP expressing cells were retained. The liposomes convey double
ﬂuorescence properties: a green ﬂuorescence of the lipophilic dye,
NBD-DOPE embedded in the lipid interface and a red ﬂuorescence
of the encapsulated DY-676-COOH (Fig. 1A). Intact liposomes are
quenched and hence characterized by double absorption peaks
(Fig. 1B, Absorption) and low ﬂuorescence emission of the DY-676-
COOH (Fig. 1B, Emission), whereas freeze-damaged liposomes lead
to release of the encapsulated DY-676-COOH resulting in activation,
which is characterized by a single absorption maximum at 670 nm
and almost 3 fold increase in ﬂuorescence emission. This effect was
consistent in newly prepared liposomes as well as those stored for
12 months at 4 C (Fig. 1B, FAP-IL*). Furthermore, serum (50% FCS)
which inﬂuences the spectroscopic properties of free DY-676-COOH
(Fig. 1C, DY-676-COOH) revealed only minimal inﬂuence on dye
release from the FAP-IL (Fig. 1C, Absorption). Thus, less than 50
arbitrary units of ﬂuorescence emission was determined for a 3
years old FAP-IL stock after treatment with serum, compared to 100
arbitrary units for equivalent amount of the free DY676-COOH
(Fig. 1C, Emission).
Also, the speciﬁcity of the FAP-IL to bind FAP expressing cells
was evident in a time dependent increase in speciﬁc liposomal
green/red ﬂuorescence of ﬁbrosarcoma cells which stably express
the human FAP protein (Fig. 2A). Interestingly, energy depletion
prevented internalization and activation of the FAP-IL in these cells,
but not the binding to the cell surface (Fig. 2A, 4 C). Likewise,
murine FAP expressing cells revealed characteristic ﬂuorescence of
FAP-IL (Fig. 2B), substantiating the cross reactivity of FAP'scFv for
murine and human FAP. In contrast, neither LipQ nor the free DY-
676-COOH was taken up by the FAP-expressing cells, supporting
the selectivity of FAP-IL for its target. Furthermore, FAP-negative
wild type HT1080 cells revealed no uptake of the liposomes or
free DY-676-COOH (Fig. 2C), whereas the phagocytic murine
macrophage cell line, J774A.1 revealed phagocytic uptake of the
liposomes as well as the free DY-676-COOH (Fig. 2D).
3.2. FAP-IL detects HT1080-hFAP cells with high migration and
invasive features in vitro
The transfected HT1080-hFAP and wildtype HT1080 cells were
subjected to classical wound healing assays in the presence or
absence of FAP-IL and observed for migration into the “wound
ﬁelds”. A rapid closure of the “wound ﬁelds” due to cell migration of
the HT1080-hFAP cells could be seen (Fig. 3A). Likewise, the
HT1080-wt cells led to almost 80% of gap closure which however,
was primarily due to rapid cell division rather than cell migration.
With respect to this, HT1080-wt cells in the wound ﬁelds remained
attached together without visible lamellipodia and ﬁlopodia
(Fig. 3A, HT1080-wt), whereas the HT1080-hFAP cells were partly
seen as single cells or cell clusters with visible lamellipodia and
ﬁlopodia (Fig. 3A, green and red arrows). The human melanoma cell
Table 1
Characterization of liposomes by dynamic light scattering.
Liposome Size [nm] Polydispersity Index (PDI) Zeta potential [mV] CDy676-COOH [mg/ml]
LipQ 128.1 ± 1.65 0.072 ± 0.019 10.9 ± 0.71 161.6
LipQa 121.4 ± 1.60 0.047 ± 0.033 15.7 ± 0.14 153.6
FAP-IL 139.1 ± 2.5 0.079 ± 0.02 15.4 ± 4.9 148.6 ± 5
FAP-ILa 135.0 ± 0.4 0.137 ± 0.019 17.8 ± 1.13 117.4 ± 15
a Depicts liposomes after storage in 10 mM Tris, pH 7.4 for 12 months at 4 C.
Fig. 1. Quenched FAP-IL is activatable in vitro. (A) Structure of the NIRF dye, DY-676-COOH, control LipQ and FAP-IL. (B) Representative absorption and emission spectra of the free
DY-676-COOH and the respective liposomal formulations (100 nmol ﬁnal lipid) before and after freeze damage. FAP-IL* depicts the probe 12 months after preparation and storage at
4 C. The free DY-676-COOH was used at a concentration encapsulated in 100 nmol of LipQ. (C) Representative absorption and emission spectra of FAP-IL** (3 years old stock) and
equivalent amount of the free DY-676-COOH after incubation in 10 mM Tris buffer (control) or after pre-treatment with 50% FCS at 37 C for 4 h (Serum).
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Fig. 2. Speciﬁcity of FAP-IL for FAP-expressing cells. (A) Confocal microscopic images of human FAP-expressing cells after incubation with FAP-IL* and LipQ (200 nmol lipids) or
free DY-676-COOH (concentration equivalent to the content of LipQ used) for 4 h, 8 h and 22 h at 37 C or for 4 h at 4 C. Corresponding confocal microscopic images of murine FAP-
expressing, HT1080-mFAP cells (B), wild type FAP-negative HT1080-wt cells (C) or highly phagocytic murine macrophage, J774A.1 cells (D) at 8 h post treatment with FAP-IL*, LipQ
or free DY-676-COOH at 37 C.
F.L. Tansi et al. / Biomaterials 88 (2016) 70e82 75line MDA-MB435S which has a low level of endogenous FAP
expression, but is marked by slow growth revealed only about 50%
of gap closure after 24 h. Interestingly, single cells with extensive
ﬁlopodia could be seen in the wound ﬁelds (Fig. 3A, MDA-MB435S,
red arrows).
The expression of FAP by themotile HT1080-hFAP cells and their
binding selectivity to FAP-IL was substantiated by wound healing
assay in the presence of 100 nmol (ﬁnal lipid concentration) of the
liposomes (Fig. 3B). Confocal microscopy revealed the HT1080-
hFAP cells as elongated cells with characteristic liposomal green
and red ﬂuorescence. This reﬂects the ability of the cells to bind,
take up, and activate the liposomes (Fig. 3B, HT1080-hFAP).
Opposed to this, the HT1080-wt is seen as adherent cells lacking
lamellipodia and ﬁlopodia and also no ﬂuorescence, due to the
inability to bind the liposomes (Fig. 3B, HT1080-wt). When grown
on the same chamber on adjacent sides of thewound ﬁeld, both cell
lines grow and ﬁll the gap, but can be easily distinguished by their
morphological differences and speciﬁcity to the FAP-IL (Fig. 3B,
HT1080-hFAP/HT1080-wt).
We further investigated the ability of the cells to migrate
through a matrix membrane. An overall high invasion potential of
the HT1080-wt cells on transwell membranes composed of ECM
proteins was seen. However, the HT1080-hFAP revealed a signiﬁ-
cantly higher (*P ¼ 0.002, ManneWhitney rank sum test) invasion
potential than the HT1080-wt cells (Fig. 3C), whereas the mela-
noma cell line MDA-MB435S revealed a very low ability to invade
the matrix. The invasion potential of MDA-MB435S cells was
similar to that of HT1080-wt cells in culture medium without
serum.3.3. FAP-IL enables in vivo and ex vivo NIRF imaging of spontaneous
metastases in mice
Mice that were subcutaneously co-implanted with the humanﬁbrosarcoma cell line HT1080 and its FAP expressing counterpart,
HT1080-hFAP for 4e8 weeks revealed altered growth of the
HT1080-hFAP and metastases formation (see Table 1 and Fig. 1 in
Ref. [31]).
With the knowledge that FAP expression enhanced formation of
metastasis in mice with double implants, we next veriﬁed the
ability of the FAP-IL to access and detect these metastatic lesions.
Mice were intravenously injected with FAP-IL or the control LipQ at
30 mmol (lipid)/kg body weight and imaged for 24 h before
dissection. Owing to the poor growth of the implanted HT1080-
hFAP tumors, accumulation and minimal ﬂuorescence activation
of both FAP-IL and control LipQ could be seen in the primary
HT1080-wt tumors, which could be clearly distinguished from
background ﬂuorescence at 24 h post injection (Fig. 4A, dorsal).
Imaging the ventral side of the mice revealed faint ﬂuorescence of
the thorax region which corresponded well with the ﬂuorescence
of the lungs (Fig. 4A, ventral). This was especially distinct for the
mice which received FAP-IL, and correlated well with the ﬂuores-
cence signals of metastastic nodules seen in excised lungs (Fig. 4B,
NIRF image). The control LipQ also accumulated in the primary
tumors and metastatic lung lesions, but to a lesser extent than FAP-
IL. The access of liposomes to tumors and metastatic nodules
depend on several factors including vasculature and the presence of
target cells such as macrophages and FAP expressing cells. There-
fore, the lack of LipQ-based ﬂuorescence in some lung metastatic
lesions was not surprising (Fig. 4B, compare NIRF image with pho-
tographs). We further veriﬁed the smallest detectable lung meta-
static lesion by imaging a representative lung excised 24 h post
injection of FAP-IL, together with a caliper and could determine
ﬂuorescence in lesions with approximately 2 mm diameter
(Fig. 4C).
Fig. 3. FAP-IL detects FAP-induced motile and invasive cancer cells in vitro. (A) Light microscopic images of cells stained with crystal violet cell staining solution, 24 h after their
growth into inserted wound ﬁelds. The arrows depict migrating cells with lamellipodia (red arrows) or without lamellipodia (green arrows). (B) Confocal microscopic images of cells
withinwound ﬁelds after 24 h growth in the presence of FAP-IL (100 nmol lipids). HT1080-hFAP and HT1080-wt cells were either grown separately or together on adjacent sides of a
separating glass slip (HT1080-hFAP/HT1080-wt: denoted “1” and “2” respectively) in cell culture chamber slides before scratching wound ﬁelds between them. HT1080-hFAP cells in
the scratched gaps reveal a distinct formation of lamellipodia/ﬁlopodia and also green and red ﬂuorescence of FAP-IL. (C) Invasion of cells through matrix membrane. The optical
density of cells that migrated through a basement matrix was derived by 3 experiments. Each bar represents mean of n ¼ 3 ± standard deviation (SD). There is a signiﬁcant
difference, (*P ¼ 0.002 by Mann Whitney rank sum test) in invasiveness for HT1080-hFAP versus HT1080-wt cells. Only very few of the human melanoma MDA-MB435S cells
migrated through the basement matrix.
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Fig. 4. FAP-IL based NIRF detection of spontaneous metastases in mice. (A) Representative mice 8 weeks post subcutaneous implantation of wild type and FAP-expressing
ﬁbrosarcoma HT1080 and HT1080-hFAP cell lines. Mice were intravenously injected with FAP-IL or the control LipQ (30 mmol lipids/kg body weight) and images made 24 h
post injection. (B) Corresponding NIRF images and photographs of lungs excised 24 h post injection of FAP-IL and LipQ, respectively. Black arrows depict visible metastatic lesions.
(C) Determining the size of the smallest detectable lung metastasis. An alignment of the ﬂuorescent metastatic nodules and the size determined by the caliper reveals ﬂuorescence
in metastases of 2 mm diameter.
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cancerous lymph nodes in an intraoperative model in mice
We further veriﬁed if FAP-IL will enable detection of metastatic
lesions which lie in regions or tissues that are difﬁcult to reach by
light or distinguish with the eyes. Mice with double implants were
injected intravenously with FAP-IL and subjected to live imaging of
the dissection process 22 h post injection. Although the liposomal
components were predominantly located in the gastrointestinal
tract, gall bladder and kidneys at this time point (Fig. 5A, image 1),
the high ﬂuorescence signal of these organs did not interfere with
the detection of metastatic lesions, since they also revealed very
strong ﬂuorescence in most cases (Fig. 5A, images 2e5). Hence,
metastatic lesions attached to the pancreas could be detected
(Fig. 5A/B image 2, pink arrows and Video-V1). In all cases the gall
bladder showed the highest ﬂuorescence intensities (Fig. 5A/B,
green arrows). Furthermore, removal of the gastrointestinal tract
revealed detection of metastases attached to the colon (Fig. 5A/B
image 3, pink arrow and Video-V2), and suspicious nodules located
near the kidneys (Fig. 5A/B image 4, pink arrows and Video-V3).
Also, swollen cancerous lymph nodes (Fig. 5A/B image 5, yellow
arrows and Video-V4) and tiny sentinel lymph nodes located under
the primary tumors (Video-V5) could be detected based on their
strong ﬂuorescence signals.
Supplementary data related to this article can be found online at
http://dx.doi.org/10.1016/j.biomaterials.2016.02.028.3.5. FAP-IL is processed in liver and kidney and eliminated in urine
and feces
It was interesting to observe high ﬂuorescence of the gastro-
intestinal tract, 22 h post injection of the liposomes. We therefore
veriﬁed the distribution of the liposomal ﬂuorescence and quan-
tiﬁed their levels in the organs excised 24 h post injection. As
already seen in live imaging, the ﬂuorescence of the gastro-
intestinal tract persisted till 24 h, irrespective of the liposomal
formulation (Fig. 6A). Semi-quantitative analysis revealed the
highest intensities in the gall bladder, jejenum, ileum and colon and
also in kidneys, whereas the livers revealed comparably low ﬂuo-
rescence of the liposomes at this time point (Fig. 6B). The free DY-
676-COOH (at a concentration equivalent to the dye content of LipQ
used) revealed only minimal ﬂuorescence in the stomach and
kidneys 24 h post injection (Fig. 6, DY-676-COOH).
In previous life imaging experiments, the livers revealed very
strong ﬂuorescence at 4e15 h post injection of the liposomes
(Video-V6), indicating that high levels of the liposomes pass
through the liver at earlier time points post injection, before being
secreted to the gall bladder and further to organs such as the
gastro-intestinal tract for elimination. To verify this, mice were
euthanized 6 h post injection of FAP-IL or LipQ and the liver and
kidneys excised. Fresh sections of the liver and kidneys were pre-
pared immediately after dissection and imaged by confocal mi-
croscopy as illustrated in the methods section. Strong liposomal
green and red ﬂuorescence was detected in liver kupffer cells, he-
patocytes and bile canaliculi (Fig. 7A, Liver) and in the tubules
located in the kidney pyramids (Fig. 7A, Kidney). A larger number of
Fig. 5. FAP-IL based intraoperative detection of spontaneous metastases and lymph nodes in mice models. (A) Representative images of ﬂuorescence distribution in mouse
organs and spontaneous metastases, 22 h post injection of FAP-IL. Pink arrows point metastatic lesions detected on the pancreas (2), colon (3) and underneath the kidney (4). Yellow
arrows depict swollen cancerous lymph nodes (5), whereas green arrows point the gall bladder. (B) Corresponding photographs displaying the metastatic lesions and lymph nodes
detected by life intraoperative ﬂuorescence imaging.
F.L. Tansi et al. / Biomaterials 88 (2016) 70e8278kupffer cells were seen in the liver of mice that received FAP-IL
(Fig. 7A, FAP-IL, pink arrows) than in those injected with LipQ
(Fig. 7A, LipQ pink arrows), whereas the distribution of the lipo-
somal ﬂuorescence in hepatocytes and bile canaliculi (Fig. 7A,white
arrows) as well as the kidney were similar, irrespective of the
liposome formulation applied.
Supplementary data related to this article can be found online at
http://dx.doi.org/10.1016/j.biomaterials.2016.02.028.
It was important to verify whether the liposomal ﬂuorescent
components are thus excreted after degradation in the liver and
kidney. We therefore collected urine and fecal pellets from mice at
different time points between 0 h and 24 h post injection of FAP-IL
and subjected them to NIRF imaging. The urine as well as feces
revealed strong liposomal ﬂuorescence signals, which increased
with increase in duration and peaked at 8e10 h post injection
(Fig. 7B, NIRF images). This indicates that the liposomes are thus
broken down and the components eliminated to a lesser degree inurine and predominantly in feces, explaining the high ﬂuorescence
in the gut and colon (Fig. 7B, bar diagram).
4. Discussion
Despite the progress met in cancer diagnostics and therapy,
surgical resection remains the best intervention of choice for most
cancer patients. However, relapse with multiple metastases is re-
ported in many patients, and can largely be ascribed to inaccurate
and incomplete surgical processes [16,34,35]. Molecular ﬂuores-
cence imaging has the potential to improve the accuracy and
completeness of the resection process, since the oncologist can see
the cancerous margins and metastatic lesions in real time. There-
fore, selective contrast agents are needed which would enable
molecular imaging of the cancerous tissues and cancerous lymph
nodes during the surgical process. We show here that activatable,
FAP-targeting liposomes enable the selective, image-guided
Fig. 6. Ex vivo biodistribution of ﬂuorescent probes in excised mice organs. A.) Representative NIRF images of organs 24 h post injection of FAP-IL, LipQ or free DY-676-COOH. B.)
Corresponding semi-quantitative analysis of the ﬂuorescence intensities of regions of interest of the organs 24 h post injection (n ¼ 4 ± SEM).
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metastases.
Stable FAP-expression by ﬁbrosarcoma cells inﬂuenced their
motility and invasiveness and led to the formation of spontaneous
metastases whichwere detectablewith FAP-IL. The inﬂuence of FAP
on the ﬁbrosarcoma cells (HT1080-hFAP) in in vitro tests ranged
from morphological changes with increased lamellipodia and ﬁlo-
podia, increased motility into scratched “wound ﬁelds” and
migration through a matrix membrane. These features correlate
well with observations that increased expression of FAP modulates
directionality and invasiveness of tumor cells [9]. In in vivo studies
however, HT1080-hFAP implanted alone led to relatively normal
tumor growth, high levels of lung hyperplasia, but lower rates of
spontaneous metastases than in setups where the wild type
HT1080-wt and stable HT1080-hFAP cells were co-implanted
adjacent to each other. This represented a suitable model for the
study of spontaneous metastasis, as demonstrated in Fig. 2 of [31].
The fact that mice with double implants (HT1080-wt and HT1080-
hFAP) revealed a higher metastatic potential than the respective
cell lines implanted alone suggests that FAP induced motility of
HT1080-hFAP is sufﬁcient for their migration from the primary
tumors, intravasation into blood vessels and circulation in the
system, whereas the necessary factors that favor their reattach-
ment at distant organs and growth to metastatic lesions is probably
offered by the wildtype HT1080-wt. This suggests that the HT1080-
hFAP in the co-implantation setup mimics FAP-expressing tumor
myoﬁbroblasts thereby inﬂuencing the invasiveness of tumor cells,and strengthens the need for optimized and accurate FAP-based
detection and surgical intervention for cancers with high FAP
expression.
The FAP-IL reported herewith, retained a characteristic ﬂuo-
rescence quenching and activation potential, due to the encapsu-
lated high concentrations of the NIRF dye, DY-676-COOH. Minimal
effect of serum on the release of the liposomal DY-676-COOH and
dequenching was noted in in vitro studies, whereas a strong in-
ﬂuence of serum proteins is generally seen for most ﬂuorochromes,
including DY-676-COOH as detailed elsewhere [21]. The fact that
the cellular uptake experiments were conducted with media con-
taining serum and that free DY-676-COOH cannot be taken up by
the tumor cell lines used (see Fig. 2), the selective binding of FAP-IL
by FAP expressing cells at 4 C and its uptake by both murine- and
human-FAP expressing cells at 37 C indicates that FAP-IL remains
intact and is taken up as quenched vesicles and activated within the
cells. This is evident in the vesicular localization of the liposomal
ﬂuorescence and was described earlier [22]. The advantage of
ﬂuorescence quenching is a high target signal-to-background
ﬂuorescence detected, since increased ﬂuorescence emission is
guaranteed exclusively after uptake and degradation of the lipo-
somes by target cells. Owing to the activatability and target selec-
tivity of FAP-IL, ﬂuorescing lung lesions could be detected in vivo
and ex vivo and correlated to tiny metastatic lesions of approxi-
mately 2 mm diameter. Opposed to this, the control LipQ is taken
up predominantly by phagocytosis [21] (also see Fig. 2), and acti-
vated by tumor associated macrophages. As a consequence, only
Fig. 7. Activation and elimination of FAP-IL and LipQ via liver hepatocytes and kuppfer cells. (A) Representative confocal microscopic images of fresh liver and kidneys, 6 h post
injection of FAP-IL and LipQ, respectively. The liposomal green/red ﬂuorescence is located in kupffer cells (pink arrows) and bile canaliculi between hepatocytes (white arrows) and
in tubules located within the pyramids of kidneys. Blue depicts tissue auto-ﬂuorescence of the fresh organs. (B) NIRF images of urine and feces collected at indicated time points
post injection of FAP-IL, and corresponding semi-quantitative analysis of their ﬂuorescence intensities (n ¼ 3 ± SD).
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tases of approximately 5 mm diameter. In order to access the me-
tastases, the intravenously injected liposomes need blood vessels
and target cells within the metastatic lesions. The ﬁndings expose
that the lung lesions of approximately 2 mm diameter already
possess well established tumor stroma and vessels, hence acces-
sible by FAP-IL. The fact that the control LipQ detected only largelung metastasis with diameters of approximately 5 mm upwards,
suggests that the presence and level of macrophages in such large
metastatic lesions is sufﬁcient to activate detectable levels of LipQ,
whereas smaller lesions probably have too low levels of macro-
phages to grant detectable activation of the non-targeted lipo-
somes. This substantiates the selectivity and superiority of FAP-IL
for optimized detection of small metastatic lesions compared to the
F.L. Tansi et al. / Biomaterials 88 (2016) 70e82 81non-targeted LipQ. Opposed to the liposomes which thanks to
PEGylation circulate longer in in vivo setups, the phagocytic uptake
of the free DY-676-COOH (see Fig. 2D) is not detectable in in vivo
situations. This is due to its small size which is prone to rapid
perfusion, strong background signals [21,30] and rapid clearance
from the system.
In simulations of intraoperative imaging, the beneﬁts of FAP-IL
were further explored. Despite a strong background ﬂuorescence
of the gastro-intestinal tract, tiny, strongly ﬂuorescing sentinel
lymph nodes and lesions were detected on the pancreas, colon and
near the kidneys, especially when the gastrointestinal tract was
moved to the side (Video-V2). In the absence of ﬂuorescence, these
metastatic lesions would remain undetectable; since they cannot
be easily distinguished from the surrounding tissues (see Fig. 5B).
Based on the strong ﬂuorescence of the lesions, it is clear that they
possess vessels that are accessible by FAP-IL. Considering that the
liposomes were applied intravenously, their accumulation in
sentinel lymph nodes (Video V5) indicates a possible drainage
either from the primary tumors, metastatic lesions or directly from
the blood vessels to the lymph nodes. This could be shown for
intravenously applied ﬂuorescent dyes [36], and supports the po-
tency of FAP-IL as a contrast agent for image-guided surgery of
cancers with high FAP expression and also for staging of cancer
patients based on lymph node imaging. Taken together, FAP-IL
enables detection of small metastatic lesions based on its ability
to access and selectively bind and be taken up by the tumor cells
within the metastatic lesions.
To deﬁne the organs suitable for imaging with FAP-IL and to
eliminate adverse side effects that may result from long retentions
of FAP-IL in particular organs, we further studied the bio-
distribution and clearance of the liposomes. We pinpoint the
liposomal ﬂuorescence to hepatocytes, bile canaliculi and kupffer
cells of the liver and to tubules of the kidney pyramids, 6 h post
injection. Kupffer cells make up 80e90% of tissue macrophages in
the body and thus confer the liver central roles in systemic and
regional defense [37]. The participation of kupffer cells in the
degradation of the FAP-IL and LipQ is substantiated by the lipo-
somal ﬂuorescence detected within the cells and expose a co-play
of hepatocytes and kupffer cells in the continues degradation and
secretion of the liposomal components to the bile, fromwhere their
proper elimination via the gut is granted. This secretion to the bile
is evident in the strong ﬂuorescence signal in the gall bladder and
the subsequent elimination via the intestinal tract in urine and
feces. Owing to the route of excretion, a high level of ﬂuorescence is
detected in the gastro-intestinal tract including the stomach. It is
not exactly clear how the ﬂuorescent probes enter the stomach of
the mice. One logical explanation is a direct digestive secretion
from the liver (via bile) and pancreas to the stomach, similar to the
liver and pancreas secretion to the duodenum in humans, or
possibly reﬂuxes from the duodenum to the stomach. However, we
do not believe that this is due to reﬂux, since the ﬂuorescence in-
tensity increased in the stomach with increasing duration post
injection, even when no further ﬂuorescence increase was seen in
the duodenum. Interestingly, the free DY-676-COOH at equivalent
concentrations like liposomal dye content was almost completely
eliminated from the organs including the stomach revealing that
the liposomal DY-676-COOH will eventually be cleared.
The low ﬂuorescence signals of the urine compared to feces
exposes a predominant fecal excretion of the FAP-IL components.
This can be ascribed to the low lipophilicity of the encapsulated DY-
676-COOH, which possesses only two sulphonate groups. It could
be shown in previous reports that increase in number of sulphonate
groups increases the lipophilicity of cyanine dyes and inﬂuences
their elimination routes, whereby highly lipophilic dyes were
preferentially eliminated in urine [38]. We therefore propose thatthe encapsulated DY-676-COOH be changed for a more lipophilic
dye when imaging of lesions within organs such as the liver, gut
and colon regions is involved.
Taken together, we demonstrate that FAP-IL is a potent contrast
agent for image-guided detection of high FAP-expressing metas-
tases and sentinel lymph nodes. Based on its ﬂexibility, FAP-IL can
be modiﬁed with different ﬂuorescent dyes for intraoperative im-
aging of colon cancers and metastasis of the gastrointestinal tract
and for endoscopic applications of disease diagnosis. Considering
the high expression of FAP on tumor andmetastatic myoﬁbroblasts,
the application of FAP-IL is feasible for a broad spectrum of me-
tastases even those originating from tumor cells which lack the
expression of FAP.
5. Conclusion
Our ﬁndings reveal that activatable FAP-IL is a potent contrast
agent for real time intraoperative imaging of a broad spectrum of
metastases originating from tumor cells with high FAP expression
as well as tumor cells which lack the expression of FAP, if the me-
tastases exhibit a high level of FAP positive myoﬁbroblasts.
Furthermore, the ﬂexibility of the liposome for modiﬁcations pro-
vides a backbone for replacement of the encapsulated NIRF dye for
applications where ﬂuorescence originating from probe elimina-
tion routes poses a hindrance. We therefore strongly believe that
the use of FAP-IL for intraoperative imaging will improve the ac-
curate and complete resection of tumors and cancerous lymph
nodes and increase the survival of cancer patients.
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